Pimavanserin: A Truly Effective Treatment for Parkinson’s Disease Psychosis? A Review of Interventions

Parkinson’s disease (PD) is the second-most common neurodegenerative disorder with a long-term 60% cumulative prevalence of PD psychosis. Medical treatment is limited to few atypical antipsychotic drugs with low affinity to dopamine D2 receptors. In 2016, pimavanserin, a selective 5-HT2A inverse ago...

Descripción completa

Detalles Bibliográficos
Autores principales: Heim, Beatrice, Peball, Marina, Krismer, Florian, Djamshidian, Atbin, Seppi, Klaus
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10239266/
https://www.ncbi.nlm.nih.gov/pubmed/37274140
http://dx.doi.org/10.2147/NDT.S371641

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10239266/
https://www.ncbi.nlm.nih.gov/pubmed/37274140
http://dx.doi.org/10.2147/NDT.S371641

Ejemplares similares